Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Implications of geographical variation on clinical outcomes of cardiovascular trials.

Mentz RJ, Kaski JC, Dan GA, Goldstein S, Stockbridge N, Alonso-Garcia A, Ruilope LM, Martinez FA, Zannad F, Pitt B, Fiuzat M, O'Connor CM.

Am Heart J. 2012 Sep;164(3):303-12. doi: 10.1016/j.ahj.2012.06.006. Epub 2012 Aug 3. Review.

PMID:
22980295
2.

Conduct of clinical trials in acute heart failure: regional differences in heart failure clinical trials.

Fiuzat M, Califf RM.

Heart Fail Clin. 2011 Oct;7(4):539-44. doi: 10.1016/j.hfc.2011.06.004. Review.

PMID:
21925437
3.

Global patterns of health care for acute coronary syndromes.

Sinnaeve PR, Van de Werf FJ.

Curr Opin Cardiol. 2004 Nov;19(6):625-30. Review.

PMID:
15502510
4.
5.

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology.

Circulation. 2007 May 15;115(19):2549-69. Review.

6.

Pediatric cardiovascular safety: challenges in drug and device development and clinical application.

Bates KE, Vetter VL, Li JS, Cummins S, Aguel F, Almond C, Dubin AM, Elia J, Finkle J, Hausner EA, Joseph F, Karkowsky AM, Killeen M, Lemacks J, Mathis L, McMahon AW, Pinnow E, Rodriguez I, Stockbridge NL, Stockwell M, Tassinari M, Krucoff MW.

Am Heart J. 2012 Oct;164(4):481-92. doi: 10.1016/j.ahj.2012.07.019.

PMID:
23067905
8.

The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.

Houston MC.

Ther Adv Cardiovasc Dis. 2010 Jun;4(3):165-83. doi: 10.1177/1753944710368205. Epub 2010 Apr 16. Review.

PMID:
20400494
9.

Consideration of regional difference in design and analysis of multi-regional trials.

Hung HM, Wang SJ, O'Neill RT.

Pharm Stat. 2010 Jul-Sep;9(3):173-8. doi: 10.1002/pst.440.

PMID:
20872619
10.

Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

Gottlieb LK, Salem-Schatz S.

Arch Intern Med. 1994 Sep 12;154(17):1945-53. Review.

PMID:
8074598
11.

Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease.

Johnson SM, Karvonen CA, Phelps CL, Nader S, Sanborn BM.

J Womens Health (Larchmt). 2003 Jun;12(5):449-57. Review.

PMID:
12869292
12.

Targeting the aldosterone pathway in cardiovascular disease.

Gustafsson F, Azizi M, Bauersachs J, Jaisser F, Rossignol P.

Fundam Clin Pharmacol. 2012 Feb;26(1):135-45. doi: 10.1111/j.1472-8206.2011.01004.x. Epub 2011 Nov 2. Review.

PMID:
22044496
13.

The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.

Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W.

Circulation. 2006 Dec 19;114(25):2871-91. Review. No abstract available.

14.

Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.

Kandzari DE, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Harrington RA, Ohman EM, Gibler WB, Peterson ED.

Am Heart J. 2005 Mar;149(3):474-81.

PMID:
15864236
15.

Maximizing scientific knowledge from randomized clinical trials.

Gustafsson F, Atar D, Pitt B, Zannad F, Pfeffer MA; participants in 10th Cardiovascular Clinical Trialists Workshop.

Am Heart J. 2010 Jun;159(6):937-43. doi: 10.1016/j.ahj.2010.03.002. Review.

PMID:
20569703
16.

Ethical and scientific implications of the globalization of clinical research.

Andrews CA.

N Engl J Med. 2009 Jun 25;360(26):2793; author reply 2793. No abstract available.

PMID:
19557890
17.

Ethical considerations in industry-sponsored multiregional clinical trials.

Ibia E, Binkowitz B, Saillot JL, Talerico S, Koerner C, Ferreira I, Agarwal A, Metz C, Maman M.

Pharm Stat. 2010 Jul-Sep;9(3):230-41. doi: 10.1002/pst.458.

PMID:
20824884
18.

Biomarker-guided therapies in heart failure: a forum for unified strategies.

Fiuzat M, O'Connor CM, Gueyffier F, Mascette AM, Geller NL, Mebazaa A, Voors AA, Adams KF, PiƱa IL, Neyses L, Muntendam P, Felker GM, Pitt B, Zannad F, Bristow MR.

J Card Fail. 2013 Aug;19(8):592-9. doi: 10.1016/j.cardfail.2013.05.012.

PMID:
23910590
19.

[Globalization of clinical trials].

Akaza H, Fukuoka M, Ohtsu A, Usami M, Ikeda T, Aiba K, Isonishi S, Ohashi Y, Saijo N, Sone S, Tsukagoshi S, Tsuruo T, Kato M, Mikami O, Dong RP, von Euler M, Blackledge G, Stribling D.

Gan To Kagaku Ryoho. 2003 Apr;30(4):555-65. Japanese.

PMID:
12722692
20.

Evaluation of quality of life in clinical trials of cardiovascular disease.

Fletcher AE, Hunt BM, Bulpitt CJ.

J Chronic Dis. 1987;40(6):557-69. Review.

PMID:
3298295

Supplemental Content

Support Center